Jones Trading Downgrades ESSA Pharma to Hold
Portfolio Pulse from Benzinga Newsdesk
Jones Trading analyst Soumit Roy has downgraded ESSA Pharma (NASDAQ:EPIX) from Buy to Hold.
November 01, 2024 | 12:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jones Trading has downgraded ESSA Pharma from Buy to Hold, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by a reputable analyst suggests a less favorable view on the stock's potential performance, which could lead to a negative short-term impact on the stock price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100